Clik here to view.
Oramed touts phase Ib data for type 2 diabetes capsule
Oramed Pharmaceuticals (NSDQ:ORMP) said today that it finished a phase Ib study of its oral GLP-1 analog capsule for type 2 diabetes. Glucagon-like peptide-1 (GLP-1) is a hormone that stimulates the...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 29, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
NeuroMetrix wins CE Mark for Quell wearable pain relief device
NeuroMetrix (NSDQ:NURO) said today it won CE Mark approval in the European Union for its Quell wearable pain relief device, now cleared as a class IIa medical device in the region. The Waltham,...
View ArticleClik here to view.
Philips launches Intellispace Portal 9.0 radiological visual analysis &...
Royal Philips (NYSE:PHG) said today it launched its IntelliSpace Portal 9.0, the most recent iteration of its radiological visual analysis and quantification platform. The new version of the platform...
View ArticleClik here to view.
Celgene invests in GNS
Celgene (NSDQ:CELG) said this week that it has made another investment in GNS Healthcare and inked a deal with the bioanalytics firm for its “Reverse Engineering and Forward Simulation” software. GNS’s...
View ArticleClik here to view.
Smart patch monitors blood, releases blood thinners to prevent clots
Researchers from the North Carolina State University and the University of North Carolina at Chapel Hill have developed a patch designed to monitor a patient’s blood and release blood-thinning drugs to...
View ArticleClik here to view.
West expands CMO facilities in Ireland
West Pharmaceutical Services (NYSE:WST) said today that it finished a 60,000 square foot expansion of its contract manufacturing facility near Mulhuddart, County Dublin in Ireland. The expansion is a...
View ArticleClik here to view.
Moximed launches IDE trial of Atlas unicompartmental knee
California orthopedic device developer Moximed said today it enrolled the 1st patient in an FDA approved investigational device exemption trial of its next-gen Atlas unicompartmental unloading knee...
View ArticleClik here to view.
Developing contextual tools for interpreting pediatric brain scans
Radiologists who can tune in to the nuances of brain scans in children are a pretty rarified group. Only about 3 percent of U.S. radiologists, some 800 to 900 physicians, practice in pediatrics. Those...
View ArticleClik here to view.
Anonymous strategic investor puts another $5m into Endonovo’s Immunotronics
Endonovo Therapeutics (OTC:ENDV) said this week that it inked a $5 million deal with an anonymous strategic investor aimed at retiring its convertible debt, launching pre-clinical studies of its...
View ArticleClik here to view.
Counterfeit prescription drug tracker raises $52m
TraceLink Inc. said yesterday that it raised $51.5 million in a Series C financing round, bringing its total raised to $77 million. The round was led by Goldman Sachs Growth Equity, joining FirstMark...
View ArticleClik here to view.
OCUL registers for $40m stock sale
Ocular Therapeutix (NSDQ:OCUL) is looking to raise $40 million through a public stock offering, according to a prospectus filed with the federal Securities & Exchange Commission this week. The...
View ArticleClik here to view.
Becton Dickinson to shutter Creedmoor, N.C. plant, lay off 120
Becton Dickinson & Co. (NYSE:BDX) is reportedly shutting down its Creedmoor, N.C. plant and laying off the 120 workers that operate out of it, according to The News & Observer. The facility in...
View ArticleClik here to view.
Abbott wins CE Mark for i-Stat handheld blood tester
Abbott (NYSE:ABT) said today it won CE Mark approval in the European Union for its i-Stat Alinity handheld blood testing platform. The i-Stat Alinity system is designed to perform a wide range of blood...
View ArticleClik here to view.
Nordisk touts Tresiba insulin injection data
Novo Nordisk (NYSE:NVO) said today that data from the Devote clinical trial indicated that its injected insulin, Tresiba, reduced the risk of severe hypoglycemia when compared to insulin glargine. The...
View ArticleClik here to view.
Report: J&J raises the stakes in Actelion pursuit
Johnson & Johnson (NYSE:JNJ) has reportedly raised its offer for Swiss biotech firm Actelion Pharmaceuticals (VTX:ATLN), pressuring the company to accept a takeover deal. The companies have been in...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 30, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
WhiteClouds inks partnership deal with TeraRecon, launches 3DyourScan...
3D-printing cloud provider WhiteClouds said today it inked a partnership deal with TeraRecon and launched the 3DyourSCAN life-size anatomical model printing service. The newly launched 3DyourScan...
View ArticleClik here to view.
France’s drugs agency freezes Carmat implants after 5th death
France’s national drugs agency said today it is ordering artificial heart maker Carmat (FRA:CXT) to freeze implantation of its devices after the death of a 5th patient last month. The company distanced...
View ArticleClik here to view.
Cambridge Consultants develop miniature robot for cataract surgery
Tech development group Cambridge Consultants are developing the Axsis, a new, micro-sized robotic surgical unit designed for cataract surgery. Measuring a meager 1.8 millimeters in diameter, the Axsis...
View Article